Noncoding RNAs (ncRNAs) constitute the majority of the human transcribed genome. This
largest class of RNA transcripts plays diverse roles in a multitude of cellular processes, and …

Long noncoding RNAs (lncRNAs) have recently gained considerable attention as key
players in biological regulation; however, the mechanisms by which lncRNAs govern …

Background The long non-coding RNA PVT1 (lncRNA PVT1) has been reported to act as an
oncogenic regulator of several cancers. However, its expression and function in gallbladder …

Colorectal cancer (CRC) is one of the most common malignant carcinomas in the world, and
metastasis is the main cause of CRC-related death. However, the molecular network …

It has been determined that long noncoding RNAs (lncRNAs) are identified as a potential
regulatory factor in multiple tumors as well as multiple myeloma (MM). However, the role of …

Glioblastoma (GBM) is the most aggressive and malignant primary tumor. Angiogenesis
plays a critical role in the progression of GBM. Previous studies have indicated that long non …

Background PVT1 has emerged as an oncogene in many tumor types. However, its role in
Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) is unknown. The aim of …

The pathogenesis and the underlying mechanism of endothelial-mesenchymal transition in
prostate cancer remain unclear. Plasmacytoma variant translocation 1 (PVT1), a novel long …

It is now evident that noncoding RNAs play key roles in regulatory networks determining cell
fate and behavior, in a myriad of different conditions, and across all species. Among these …

Breast cancer (BC) remains the most frequently diagnosed cancer worldwide. Among breast
cancer patients, distant metastasis and invasion is the leading cause of BC related death …